Cargando…
Guidelines versus individualized care for the management of CINV
Numerous groups have published guidelines for the prevention and management of chemotherapy-induced nausea and vomiting (CINV). The current management of CINV, however, remains suboptimal, due in part to poor adherence to existing antiemetic guidelines. Challenges in clinical trial design have also...
Autor principal: | Clemons, Mark |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5876263/ https://www.ncbi.nlm.nih.gov/pubmed/29556809 http://dx.doi.org/10.1007/s00520-018-4115-3 |
Ejemplares similares
-
CINV: still troubling patients after all these years
por: Aapro, Matti
Publicado: (2018) -
Bringing it all together in the treatment of CINV: application of current knowledge into routine clinical practice
por: Warr, David
Publicado: (2018) -
Duration of Chemotherapy-induced Nausea and Vomiting (CINV) as a Predictor of Recurrent CINV in Later Cycles
por: Navari, Rudolph, et al.
Publicado: (2022) -
Chemotherapy-Induced Nausea and Vomiting (CINV) with GI Cancer Chemotherapy: Do We Need CINV Risk Score Over and Above Antiemetic Guidelines in Prescribing Antiemetic Regime?
por: D’Souza, Anita, et al.
Publicado: (2020) -
Helping patients discuss CINV management: development of a Patient Charter
por: Young, Annie, et al.
Publicado: (2013)